Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingling Oral Solution (also known as Jingling Oral Liquid) is a traditional Chinese medicine (TCM) herbal formula developed by Liaoning Dongfangren Pharmaceutical (also rendered as Liaoning Oriyuan Pharmaceutical). It is a multi-herb botanical mixture composed of twelve traditional Chinese medicinal ingredients, including Rehmanniae Radix Praeparata, Dioscoreae Rhizoma, Poria, Moutan Cortex, Alismatis Rhizoma, Polygalae Radix, Os Draconis, Ligustri Lucidi Fructus, Phellodendri Chinensis Cortex, Anemarrhenae Rhizoma, Schisandrae Chinensis Fructus, and Acori Tatarinowii Rhizoma. Jingling Oral Solution is approved and widely used in China for the treatment of attention deficit hyperactivity disorder (ADHD) in children, where clinical trials have demonstrated its efficacy in improving ADHD rating scale total scores and hyperactivity/impulsivity symptoms. Additionally, it has been investigated in clinical studies for the treatment of pediatric tic disorders and for improving semen quality and reproductive hormone levels in infertile men post-varicocelectomy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jingling Oral Solution.